4//SEC Filing
Carroll Khristine L 4
Accession 0001556244-19-000112
CIK 0001011060other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 6:43 PM ET
Size
8.6 KB
Accession
0001556244-19-000112
Insider Transaction Report
Form 4
Carroll Khristine L
EVP of Commercial Operations
Transactions
- Exercise of In-Money
Common Stock
2019-12-05+600,000→ 1,335,309 total - Exercise of In-Money
Common Stock
2019-12-05$0.06/sh+100,000$6,000→ 385,309 total - Exercise of In-Money
Common Stock
2019-12-05+350,000→ 735,309 total
Footnotes (3)
- [F1]Shares acquired through the exercise of options granted pursuant to the 2003 Stock Option Plan at an exercise price of $0.06 per share in consideration of cash.
- [F2]Shares acquired from the exercise of options pursuant to the 2017 Non-Qualified Equity Incentive Plan (the "2017 Plan") which provided for the exercise of options into 500,000 shares of the Company's common stock at an exercise price of $0.06 per share which were exercised on a cashless basis, as provided for in the 2017 Plan, resulting in the issuance of 350,000 shares, net.
- [F3]Shares acquired from the exercise of options granted pursuant to the 2017 Non-Qualified Equity Incentive Plan (the "2017 Plan") which provided for the exercise of options into 750,000 shares of the Company's common stock at an exercise price of $0.04 per share which were exercised on a cashless basis, as provided for in the 2017 Plan, resulting in the issuance of 600,000 shares, net.
Documents
Issuer
AdvanSource Biomaterials Corp
CIK 0001011060
Entity typeother
Related Parties
1- filerCIK 0001672352
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 6:43 PM ET
- Size
- 8.6 KB